COVID-19 VACCINE UPDATES |
|
Additional information: Third Primary Dose Yesterday we announced a third dose of the Pfizer vaccine would be available for people who are severely immuncompromised. We anticipate this option will only be suitable for a very small group of the population. continued...
The main things to note are: · A third primary dose vaccine cannot be prescribed or administered to anyone who does not meet the criteria set out in the Policy Statement. · The third primary dose must be administered at least 8 weeks following the second dose. · Patients must show a script from a medical practitioner and a written consent form (co-signed by the medical practitioner) to receive a third primary dose. · The third primary dose can be administered at all vaccination clinics. · The standard two-dose course of vaccine should be offered to any eligible unvaccinated household contacts aged 12 and over, of severely immunocompromised individuals. · The Ministry of Health has published the requirements to be eligible for a third dose (see , which can be viewed online (see Policy Statement) · Information for clinicians is available in the Immunisation Handbook and IMAC website.
The attached documents will help you understand the eligibility criteria for this third primary dose of Pfizer. This information will be loaded to the Ministry of Health’s website this afternoon. Please note the COVID-19 Vaccination Immunisation Operating Guidelines will shortly be updated to include this change. Click here to read the policy statement and clinical guidance Click here to read the third primary dose consumer access journey Issue #20 - 20 October 2021 Welcome to Issue #20 of the COVID-19 Vaccine Programme Update. This fortnightly newsletter for the health and disability sector contains a general programme update and clinical information for vaccinators. A list of resource links and subscription information completes this newsletter. In this issue: Highlights
Click here to read the full update Third dose of the Pfizer vaccine for people who are severely immunocompromised - more details20/10/2021
Third dose of the Pfizer vaccine for people who are severely immunocompromised - more details Yesterday we announced a third dose of the Pfizer vaccine would be available for people who are severely immunocompromised. We anticipate this option will only be suitable for a very small group of the population. Click here to read the full update See the below information about Raukura Hauora o Tainui's Super vax saturday Welcome to Issue #19 of the COVID-19 Vaccine Programme Update. This fortnightly newsletter for the health and disability sector contains a general programme update and clinical information for vaccinators. Click here to read the full update The Ministry has updated the advice on the timing of routine vaccines in relation to the COVID-19 vaccine. The influenza, MMR, HPV, diphtheria/tetanus/pertussis combination vaccine (Boostrix), and majority of other routine vaccines can now be administered before, after, or at the same time as the Pfizer COVID-19 vaccine, without concern for the spacing of the vaccinations. The change supports completing a person’s recommended vaccination schedule in the shortest and most effective timeframe. The only exception to this advice is for the live-attenuated shingles vaccine (Zostavax) where a 7-day interval, before or after administering Pfizer COVID-19 vaccine, is advised. This updated advice supports the uptake of the other vaccines already on the New Zealand schedule. There are no additional safety concerns associated with co-administration, over and above each vaccine’s individual safety profile. More details are available on the IMAC website https://covid.immune.org.nz/covid-19-vaccines-nz/getting-vaccinated/spacing-vaccinations |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
March 2022
Categories |
RSS Feed
